Pearls & Oy-sters: Attacks of Hemiplegic Migraine and Encephalopathy in SLC4A4 Pathogenic Variants
Abstract
Hemiplegic migraine presents as recurrent episodes of migraine with associated unilateral weakness. Patients can present with more severe paroxysmal episodes of encephalopathy. Treatment varies widely and it is not standardized. Despite the growing understanding of genetic causes of hemiplegic migraine, pathogenic variants in SLC4A4 are the only described etiology with recessive inheritance. Better understanding of the various genetic causes and associated symptoms of hemiplegic migraine would allow more personalized treatments leading to a reduction in morbidity. This case describes a 34-year-old patient with episodes of hemiplegic migraine and paroxysmal encephalopathy who was found to have homozygous SLC4A4 pathogenic variants. It describes his initial renal and ocular dysfunction in childhood followed by hemiplegic migraine in adolescence and episodes of encephalopathy in adulthood. In his most recent presentation, the patient improved after initiation of high-volume bicarbonate repletion and steroids. SLC4A4 pathogenic variants are associated with a multiorgan syndrome in which neurologic symptoms typically develop in adolescence or young adulthood. Common symptoms include hemiplegic migraine and paroxysmal attacks of acute encephalopathy. In this case, there was improvement with initiation of steroids despite no evidence of cerebral edema. Furthermore, rapid correction of pH and volume status additionally contributed to clinical improvement. Recognizing the diverse set…
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Calcium Ions in the Physiology and Pathology of the Central Nervous System
- AI-powered in silico twins: redefining precision medicine through simulation, personalization, and predictive healthcare
- In silico functional, structural and pathogenicity analysis of missense single nucleotide polymorphisms in human MCM6 gene
- In Silico drug repurposing pipeline using deep learning and structure based approaches in epilepsy
- Targeting serotonin receptors with phytochemicals – an in-silico study
- In silico exploration of anti-prostate cancer compounds from differential expressed genes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.